Cleared Special

AXIOS STENT AND DELIVERY SYSTEM (WITH 10MM X 10MM STENT) AXIOS STENT AND DELIVERY SYSTEM (WITH 15MM X 10MM STENT) (K140561) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
49d
Days
Class 2
Risk

K140561 is an FDA 510(k) clearance for the AXIOS STENT AND DELIVERY SYSTEM (WITH 10MM X 10MM STENT) AXIOS STENT AND DELI.... Classified as Pancreatic Stent, Covered, Metallic, Removable (product code PCU), Class II - Special Controls.

Submitted by Xlumena, Inc. (Mountain View, US). The FDA issued a Cleared decision on April 23, 2014 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5015 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Xlumena, Inc. devices

Submission Details

510(k) Number K140561 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2014
Decision Date April 23, 2014
Days to Decision 49 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 130d · This submission: 49d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code PCU Pancreatic Stent, Covered, Metallic, Removable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5015
Definition To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - PCU Pancreatic Stent, Covered, Metallic, Removable

All 10
Devices cleared under the same product code (PCU) and FDA review panel - the closest regulatory comparables to K140561.
Niti-S SPAXUS Stent
K252648 · Taewoong Medical Co., Ltd. · Mar 2026
AXIOS Stent and Electrocautery-Enhanced Delivery System
K220112 · Boston Scientific Corporation · Sep 2022
AXIOS Stent and Electrocautery Enhanced Delivery System
K203132 · Boston Scientific Corporation · Apr 2021
AXIOS Stent and Electrocautery Enhanced Delivery System
K192043 · Boston Scientific Corporation · Aug 2019
AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery Enhanced Delivery System
K181905 · Boston Scientific Corporation · Mar 2019
AXIOS Stent and Electrocautery Enhanced Delivery System
K163272 · Boston Scientific Corporation · Feb 2017